Roivant insider sells 1M shares after option exercise
Roivant Sciences Ltd. President & CIO Mayukh Sukhatme reported an exercise-and-sell pattern over two days.
Rhea-AI Filing Summary
Roivant Sciences Ltd. President & CIO Mayukh Sukhatme reported an exercise-and-sell pattern over two days. On June 25 and 26, he exercised options to acquire a total of 1,000,000 Common Shares at $3.85 per share and sold 1,000,000 Common Shares in open-market transactions.
The sales were executed at weighted average prices of $34.13 and $34.08 per share, each representing multiple trades within disclosed price ranges. Following these transactions, Sukhatme directly held 18,677,617 Common Shares. The underlying options exercised were fully vested and are no longer outstanding.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
Sukhatme Mayukh
Role
President & CIO
Sold
1,000,000 shs ($34.10M)
Approx. gross sale proceeds
$34.10M
Approx. exercise cost
$3.85M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 500,000 | $0.00 | $0.00 |
| Exercise | Common Shares | 500,000 | $3.85 | $1.93M |
| Sale | Common Shares | 500,000 | $34.08 | $17.04M |
| Exercise | Stock Option (Right to Buy) | 500,000 | $0.00 | $0.00 |
| Exercise | Common Shares | 500,000 | $3.85 | $1.93M |
| Sale | Common Shares | 500,000 | $34.13 | $17.07M |
Holdings After Transaction:
Stock Option (Right to Buy) — 14,224,363 contracts (Direct);
Common Shares — 18,677,617 shares (Direct)
Footnotes (3)
- F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F3. Award of stock options to purchase Common Shares that is fully vested.
Key Figures
Shares sold: 1,000,000 Common Shares
Options exercised: 1,000,000 shares
Exercise price: $3.85 per share
+4 more
7 metrics
Shares sold
1,000,000 Common Shares
Total open-market sales on June 25–26, 2026
Options exercised
1,000,000 shares
Total underlying Common Shares from option exercises
Exercise price
$3.85 per share
Conversion or exercise price of stock options
Weighted avg sale price 6/25
$34.13 per share
Common Shares sold in multiple trades, $33.75–$34.45 range
Weighted avg sale price 6/26
$34.08 per share
Common Shares sold in multiple trades, $33.87–$34.67 range
Post-transaction holdings
18,677,617 Common Shares
Directly owned after June 26, 2026 transactions
Options exercised per day
500,000 shares
Option exercises on each of June 25 and June 26, 2026
Key Terms
open-market sale, derivative exercise/conversion, Stock Option (Right to Buy), weighted average price, +1 more
5 terms
open-market sale financial
"transaction_action: "open-market sale" for non-derivative Common Shares"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion" for option-related entries"
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" in derivative records"
weighted average price financial
"The price reported in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Roivant Sciences (ROIV) report for Mayukh Sukhatme?
Roivant Sciences (ROIV) reported that President & CIO Mayukh Sukhatme exercised options for 1,000,000 Common Shares and sold 1,000,000 Common Shares in open-market transactions on June 25 and 26, 2026, reflecting an exercise-and-sell sequence rather than a simple purchase or sale.
What was the strike price of the Roivant Sciences (ROIV) options exercised?
The options exercised by Mayukh Sukhatme to acquire Roivant Sciences (ROIV) Common Shares had a conversion or exercise price of $3.85 per share. These were fully vested stock options, and the underlying derivative positions were reduced to zero as a result of the exercises.
How many Roivant Sciences (ROIV) options did Mayukh Sukhatme exercise in this filing?
In this filing, Mayukh Sukhatme exercised stock options for a total of 1,000,000 Roivant Sciences (ROIV) Common Shares. The Form 4 shows two derivative transactions, each for 500,000 option shares, both labeled as exercises or conversions of derivative securities into Common Shares.
Was Mayukh Sukhatme’s Roivant Sciences (ROIV) transaction an open-market sale?
Yes. The Form 4 describes the 1,000,000 Roivant Sciences (ROIV) Common Shares disposed as open-market sales. Each non-derivative transaction carries the code “S” and is labeled as a sale in open market or private transaction, executed at disclosed weighted average prices.
AI-generated analysis. How Rhea-AI works. Not financial advice.
